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Civilizational development causes increasing contamination with heavy metals, which leads to 
increased environmental pollution and accumulation such metals in food chains, posing a threat 
to the health and safety of humans and animals. Furthermore, commonly used active 
pharmaceutical ingredients (APIs) and their degradation products ending up in environment are 
currently a global problem. The elimination of pollution can be achieved by remediation through 
fungi, ‘mycoremediation’, which is a biological tool using the ability of mushrooms to degrade a 
wide variety of environmental pollutants e.g. APIs and to bind with toxic heavy metals present in 
the environment. Mycoremediation is a branch of biotechnology focuses mainly on the 
assessment of biodegradation capacity of different groups of mushrooms and enhancement their 
detoxification activity.  
The main areas of our interest concentrate on the assessment of ability of mushroom-based 
remediation to accumulate and degrade cephalosporin antibiotics, azole antifungals and steroid 
hormones (testosterone and 17α-ethynylestradiol). Selected drug classes are widely used as active 
ingredients in pharmaceuticals, moreover, previous studies indicate their presence in sewage or 
surface water.
 
In the case of azole antifungals, it is worth to highlight their widespread usage in 
topical preparations, and consequently their release unchanged to the environment  as well as 
their subsequent  persistence in environment. In all cases, the tested drugs were not detected at all 
or were detected in a lower amount in separated culture media, and therefore the usage of 
mycoremediation to remove them could be considered. The key stage of the research was the 
identification of presumable degradation products of the investigated APIs and their 
transformation pathways using LC/MS/MS. The potential of biomass from in vitro cultures of 
selected edible mushroom species, such as Laetiporus sulphureus (Polyporaceae), Agaricus 
bisporus (Agaricaceae) and Imleria badia (Boletaceae) in terms of the ability to accumulate 
Cd(II) and Pb(II) was also examined. The results confirm the possibility of using the tested 
mycelia from in vitro cultures, particularly the L. sulphureus species, in remediation. 
Due to the high uptake capacity, efficiency, low cost and safety, mycoremediation is now 
becoming increasingly popular technique for removing pollutants. However, further efforts are 
needed to better understand a metabolic and enzymatic degradation of the drugs by mushrooms in 
order to increase the efficiency of mycoremediation process. 
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